Rare Tumours of the Kidney
Rare malignant neoplasms of the kidney have aggressive outcomes but are not covered in most books of Urology, Surgery, and Medicine. This book focuses on these rare neoplasms, providing updated information on a heterogeneous group of disorders with distinct abnormalities.
Infantile Cancer
This book is an authoritative introduction to rare cancers in the first year of life. It explores how these malignancies differ biologically and clinically, focusing on their unique genetics, the challenges of early diagnosis, and advances in treatment and family-centered care.
This book describes photodynamic cancer treatment, a clinically proven method using light to destroy cancer cells while leaving normal cells unharmed. Treat inoperable tumors without surgery, side effects, or complications. It’s a low-cost therapy with a high survival rate.
Curative Medicine to Control Cancer
This book details a novel approach to controlling cancer with natural lignans. Instead of killing cancer cells, lignans redress malignancy by altering the tumor microenvironment to cut off its blood supply, effectively starving the cancer and leading to its gradual disappearance.
Improved cancer survival has led to a new challenge: a rise in second primary cancers. As survivors live longer, understanding these malignancies is essential for follow-up care. This book provides insights into the epidemiology, risk factors, and management of these new cancers.
This thorough study of radio-pathological correlation in breast cancer offers a pathology of the disease and 35 practical case studies. It is an essential resource for breast clinicians, pathologists, and students.
Cancer as a Reversible Disease
Cancer is a systemic disease, not just a tumor. Treatment would be more effective if it gave more importance to the logic of the body’s own physiological processes. Correct selection of treatment and close follow-up of the whole patient are key factors for improving prognosis.
Neuroblastoma in the Era of Precision Medicine
This book bridges cutting-edge research with real-world clinical applications. It offers a patient-centered, multidisciplinary approach, integrating emerging therapies like AI diagnostics and precision medicine with survivorship care, patient narratives, and actionable insights.